SIRT2 as a Therapeutic Target for Age-Related Disorders
- PMID: 22563317
- PMCID: PMC3342661
- DOI: 10.3389/fphar.2012.00082
SIRT2 as a Therapeutic Target for Age-Related Disorders
Abstract
Sirtuin proteins are conserved regulators of aging that have recently emerged as important modifiers of several diseases which commonly occur later in life such as cancer, diabetes, cardiovascular, and neurodegenerative diseases. In mammals, there are seven sirtuins (SIRT1-7), which display diversity in subcellular localization and function. SIRT1 has received much of attention due to its possible impact on longevity, while important biological and therapeutic roles of other sirtuins have been underestimated and just recently recognized. Here we focus on SIRT2, a member of the sirtuin family, and discuss its role in cellular and tissue-specific functions. This review summarizes the main scientific advances on SIRT2 protein biology and explores its potential as a therapeutic target for treatment of age-related disorders.
Keywords: SIRT2; aging; cancer; metabolic syndrome; neurodegenerative disorder.
Figures
References
-
- Alim M. A., Ma Q. L., Takeda K., Aizawa T., Matsubara M., Nakamura M., Asada A., Saito T., Kaji H., Yoshii M., Hisanaga S., Ueda K. (2004). Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein. J. Alzheimers Dis. 6, 435–442; discussion 443–439. - PubMed
-
- Beirowski B., Gustin J., Armour S. M., Yamamoto H., Viader A., North B. J., Michan S., Baloh R. H., Golden J. P., Schmidt R. E., Sinclair D. A., Auwerx J., Milbrandt J. (2011). Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling. Proc. Natl. Acad. Sci. U.S.A. 108, E952–E96110.1073/pnas.1104969108 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
